Gainers
- Shineco, Inc. (NASDAQ:SISI) shares climbed 24.5% to $1.2201 on heavy volume.
- Biomerica, Inc. (NASDAQ:BMRA) gained 23.6% to $3.6599 following news the company's breast self exam will now be available for sale in Walmart (NYSE:WMT).
- Sentage Holdings Inc. (NASDAQ:SNTG) surged 23.6% to $0.7035 after gaining 16% on Wednesday.
- Clene Inc. (NASDAQ:CLNN) shares gained 23.3% to $3.55. Clene reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8 compared to initially randomized placebo-treated participants during the long-term open-label extension of its RESCUE-ALS trial.
- SaverOne 2014 Ltd (NASDAQ:SVRE) shares gained 20.4% to $3.4799. SaverOne 2014 recently named Israel Eybi as Chief Marketing and Sales Officer.
- Yatsen Holding Limited (NYSE:YSG) jumped 18.5% to $1.7308 after declining 27% on Wednesday.
- VBI Vaccines Inc. (NASDAQ:VBIV) surged 17% to $1.0090. VBI Vaccines reported appointment of John Dillman as Chief Commercial Officer.
- Lucira Health, Inc. (NASDAQ:LHDX) gained 16.3% to $3.00. Lucira Health posted Q1 adjusted net income of $16.668 million in May.
- Revelation Biosciences, Inc. (NASDAQ:REVB) jumped 14.4% to $1.35. Revelation Biosciences completed database lock for Phase 1b CLEAR clinical study of REVTx-99b for treatment of allergic rhinitis.
- Canoo Inc. (NASDAQ:GOEV) gained 12.7% to $4.0250 after the company announced it has been awarded by the U.S. Army to supply an electric vehicle for analysis and demonstration.
- Ambow Education Holding Ltd. (NYSE:AMBO) jumped 12.2% to $0.46.
- Angi Inc. (NASDAQ:ANGI) gained 10.3% to $4.3250.
- Cemtrex, Inc. (NASDAQ:CETX) jumped 8.5% to $0.3201.
- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) surged 8.4% to $1.16.
- Theravance Biopharma, Inc. (NASDAQ:TBPH) rose 4.2% to $8.99. Theravance Biopharma agreed to sell all of its units in Theravance Respiratory Company, LLC, representing 85% economic interest in the sales-based royalty rights on worldwide net sales of GSK’s TRELEGY ELLIPTA to Royalty Pharma for over $1.5 billion.
